SILAPUR

Serial Number 87157879
606

Registration Progress

Application Filed
Sep 1, 2016
Under Examination
Mar 14, 2017
Approved for Publication
Jan 17, 2017
Published for Opposition
Jan 17, 2017
Registered

Basic Information

Serial Number
87157879
Filing Date
September 1, 2016
Published for Opposition
January 17, 2017
Abandonment Date
October 21, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 21, 2019
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Robert E. Lee, Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

26 events
Date Code Type Description
Oct 21, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 5, 2019 EXT4 S SOU EXTENSION 4 FILED
Feb 5, 2019 EX4G S SOU EXTENSION 4 GRANTED
Aug 17, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 15, 2018 EXT3 S SOU EXTENSION 3 FILED
Aug 15, 2018 EX3G S SOU EXTENSION 3 GRANTED
Feb 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 23, 2018 EXT2 S SOU EXTENSION 2 FILED
Feb 23, 2018 EX2G S SOU EXTENSION 2 GRANTED
Aug 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 16, 2017 EXT1 S SOU EXTENSION 1 FILED
Aug 16, 2017 EX1G S SOU EXTENSION 1 GRANTED
Mar 14, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 17, 2017 PUBO A PUBLISHED FOR OPPOSITION
Jan 17, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2016 DOCK D ASSIGNED TO EXAMINER
Sep 7, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2016 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for use in the treatment of metabolic diseases and disorders, maldigestion, malabsorption, and malnutrition
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005